Fern Toh

Fern Toh is a Senior Principal Scientist at AbbVie since August 2024, with extensive expertise developed through various roles at renowned organizations. Previously, Fern held the position of Senior Principal Scientist at Cerevel Therapeutics from April 2020 to August 2024, where other titles included Principal Scientist and Senior Scientist. Additional experience includes a Senior Scientist role at Alkermes and a Postdoctoral Research Associate position at Rutgers University, focusing on drug transport studies and regulatory investigations. Fern's academic background includes a Ph.D. in Medicinal Chemistry from the University of Illinois Chicago and a Bachelor's Degree in Biochemistry from Beloit College. Research skills encompass assay development, molecular biology experiments, and contributions to significant projects related to hormone-related cancers and drug transporter inhibitors.